<sup>123</sup>I-MIP-1072, a Small-Molecule Inhibitor of Prostate-Specific Membrane Antigen, Is Effective at Monitoring Tumor Response to Taxane Therapy

Shawn Hillier(Mirati Therapeutics (United States)), John W. Babich(RaNA Therapeutics (United States))

Journal of Nuclear Medicine

June 16, 2011

10.2967/jnumed.110.086751

Cited by 82

Related Papers

Glu-Ureido–Based Inhibitors of Prostate-Specific Membrane Antigen: Lessons Learned During the Development of a Novel Class of Low-Molecular-Weight Theranostic Radiotracers

|Journal of Nuclear Medicine|2017|156